Back to Search
IQBAL SIDDIQUI, D.O
D.O
Emergency Medicine Physician
NPI: 1285969980IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MB86729(NJ)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Class of 2005
Research & Publications (20)
A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome.
PMID 19462174·Arch Gynecol Obstet·2010
8-other
Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling.
PMID 19233958·Carcinogenesis·2009
8-other
Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome.
PMID 19577236·Int J Gynaecol Obstet·2009
8-other
Prevalence of overweight and obesity among children and adolescents of affluent schools in Karachi.
PMID 19213375·J Pak Med Assoc·2009
8-other
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
PMID 19223530·Cancer Res·2009
7-preclinical
(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma.
PMID 19502799·Cell Cycle·2009
7-preclinical
Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
PMID 19147749·Clin Cancer Res·2009
8-other
Diagnostic efficacy of 0, 30, 45, 60, 90 and 120 min growth hormone samples in insulin tolerance test: utility of growth hormone measurement at different time-points and a cost-effective analysis.
PMID 19110658·Scand J Clin Lab Invest·2009
8-other
Prevention of skin cancer by green tea: past, present and future.
PMID 19556855·Cancer Biol Ther·2009
7-preclinical
Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease.
PMID 19276266·Clin Cancer Res·2009
7-preclinical
Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice.
PMID 18684729·Carcinogenesis·2008
7-preclinical
Mineral supported facile synthesis of novel 4-hydroxybenzoxazin-2-thione N-nucleosides.
PMID 18696367·Nucleosides Nucleotides Nucleic Acids·2008
8-other
A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.
PMID 18922932·Cancer Res·2008
7-preclinical
Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.
PMID 18640874·Tuberculosis (Edinb)·2008
6-review
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
PMID 17998943·Oncogene·2008
8-other
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
PMID 18223692·Oncogene·2008
7-preclinical
Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model.
PMID 18317887·Pharm Res·2008
7-preclinical
Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth.
PMID 18948740·Cell Cycle·2008
8-other
Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production.
PMID 17909563·Immunol Cell Biol·2008
7-preclinical
Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
PMID 17403520·Chem Biol Interact·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9 TOWER DR
EAST HANOVER, NJ 07936 - Phone
- (973) 428-4773
Quick Facts
- NPI
- 1285969980
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile